Introduction: Single balloon enteroscopy (SBE) is a method used for evaluation of the small intestine. It is most frequently used to investigate the cause of obscure gastrointestinal (GI) bleeding, and is useful to investigate other disorders as well. In a case series of obscure overt GI bleeding, Pinto-Pais et al. demonstrated that 93.3% of patients with active bleeding underwent SBE that identified the source, and 64.3% of patients with inactive GI bleeding had a definitive bleeding source identified. The aim of our study was to evaluate the efficacy of SBE at Bellevue Hospital from its introduction at our institution in 2008 through 2015. Methods: A query of our endoscopic software was performed of SBE procedures from January 2008 through September 2015. The main inclusion criterion was patients at least 18 years of age who underwent SBE. The patient's age, past medical history, pertinent laboratory tests, procedural indications, capsule endoscopy findings, pathology results, SBE outcomes, and adverse events were collected. Results: Forty SBEs were performed during this period: twenty-nine anterograde and eleven retrograde. The average age of the patients was 51.9. Procedural indications including bleeding (18), anemia (9), retained video capsule (4), intussusception (2), mass (2), and other abnormal imaging findings (5). Nineteen procedures were successful in reaching the area in question. Diagnoses included one paraganglioma, one adenocarcinoma, one GIST, and one carcinoid. Six procedures led to treatment of AVMs with subsequent improvement in anemia. Adverse events included abdominal pain in 3 procedures. Two of these episodes resolved without intervention and the third patient was lost to follow-up. One patient had mucosal trauma and oozing. One patient had melena and a decline in hemoglobin, which resolved without intervention. One patient had a possible retroperitoneal hematoma after the procedure. Conclusion: This study outlines the diagnostic and therapeutic utility of SBE in varied clinical scenarios in the diverse patient population at Bellevue Hospital, a large tertiary care referral center in New York City. Ongoing studies would include investigating the utility of SBE in symptomatic patients without abnormal findings on imaging or laboratory studies, the use of enteroscopic localization technology to improve patient comfort, safety, and procedural efficiency, and optimizing procedural timing to determine if sensitivity and yield are enhanced.Figure: A) 73-year-old patient with obscure occult and overt GIB with video capsule endoscopy (VCE) showing blood and angioectasias. Anterograde SBE to distal jejunum showing a single non-bleeding angioectasia treated with APC. B) 78-year-old patient presented with IDA and jejunal tumor on CT. Anterograde SBE to the mid/distal jejunum showing large circumferential friable area of necrotic mucosa with overlying clot. Biopsies revealed paraganglioma, successfully managed surgically. C) 26-year-old patient with recurrent episodes of abdominal pain and intussusception. VCE demonstrated small bowel polyposis. Anterograde SBE to mid/distal jejunum demonstrated a 15mm polyp, successfully managed with saline lift-assisted polypectomy. D) 61-year-old patient with a history of colon cancer who presented with melena, IDA, and abnormal CT scan. Anterograde SBE to mid/distal jejunum revealed 5cm lesion in the third part of the duodenum, biopsies revealed invasive adenocarcinoma.
Read full abstract